Statements

We respond to new global study suggesting women dissatisfied with breast size also less likely to check themselves

Responding to a new global study (published in the journal 'Body Image') that found women who are dissatisfied with their breast size are...

6 February 2020

We respond to trial showing blood test can quickly match targeted treatments to secondary breast cancer patients

Research presented by Professor Nicholas Turner at the San Antonio Breast Cancer Symposium suggests that a blood test could be used to match patients...

17 December 2019

We respond to study suggesting that ‘oestrogen only and oestrogen plus progestin have opposite effects on breast cancer incidence in post-menopausal women’

Research presented at the San Antonio Breast Cancer Symposium suggests that oestrogen only hormone replacement therapy, otherwise known as HRT, may...

17 December 2019

We respond to major trial showing the preventive effects of anastrozole continue for over five years after women stop taking it

Research presented at the San Antonio Breast Cancer Symposium has shown that the preventative effects of anastrozole, given to some women at high...

17 December 2019

We respond to study suggesting ‘partial breast irradiation may be as effective as whole breast irradiation in preventing recurrence in patients with early breast cancer’

Research presented at the San Antonio Breast Cancer Symposium suggests that partial breast radiotherapy could be as effective as whole breast...

16 December 2019

We respond to new global study suggesting women dissatisfied with breast size also less likely to check themselves

We respond to trial showing blood test can quickly match targeted treatments to secondary breast cancer patients

We respond to study suggesting that ‘oestrogen only and oestrogen plus progestin have opposite effects on breast cancer incidence in post-menopausal women’

We respond to major trial showing the preventive effects of anastrozole continue for over five years after women stop taking it

We respond to study suggesting ‘partial breast irradiation may be as effective as whole breast irradiation in preventing recurrence in patients with early breast cancer’

We respond to new imaging method which could help breast cancer patients avoid extensive surgery

We respond to study suggesting that ‘permanent hair dye and chemical straighteners may increase breast cancer risk’

We respond to new estimations there are nearly three million people living with cancer in UK

We respond to NICE approval of palbociclib with fulvestrant for use on the Cancer Drugs Fund